These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15203921)

  • 1. Adjuvant action of melittin following intranasal immunisation with tetanus and diphtheria toxoids.
    Bramwell VW; Somavarapu S; Outschoorn I; Alpar HO
    J Drug Target; 2003; 11(8-10):525-30. PubMed ID: 15203921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies.
    Yasuda Y; Isaka M; Taniguchi T; Zhao Y; Matano K; Matsui H; Morokuma K; Maeyama J; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Jun; 21(21-22):2954-63. PubMed ID: 12798639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvanticity of pGPL-Mc and LRS in the immune responses of monkeys to oral immunization with diphtheria and tetanus toxoids.
    Mirchamsy H; Neway T; Hamedi M; Pilet C
    Comp Immunol Microbiol Infect Dis; 1997 Jan; 20(1):13-20. PubMed ID: 9023036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Kozuka S; Taniguchi T; Matano K; Maeyama J; Komiya T; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 1999 Nov; 18(7-8):743-51. PubMed ID: 10547435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal vaccination against plague, tetanus and diphtheria.
    Alpar HO; Eyles JE; Williamson ED; Somavarapu S
    Adv Drug Deliv Rev; 2001 Sep; 51(1-3):173-201. PubMed ID: 11516788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divalent toxoids loaded stable chitosan-glucomannan nanoassemblies for efficient systemic, mucosal and cellular immunostimulatory response following oral administration.
    Harde H; Siddhapura K; Agrawal AK; Jain S
    Int J Pharm; 2015 Jun; 487(1-2):292-304. PubMed ID: 25895719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the adequate composition of diphtheria and tetanus toxoids-with reference to the amounts of toxoids and aluminum adjuvant.
    Someya S; Mizuhara H; Murata R; Kurokawa M
    Jpn J Med Sci Biol; 1981 Feb; 34(1):21-35. PubMed ID: 7265558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross reactive anti-tetanus and anti-melittin Fab fragments by phage display after tetanus toxoid immunisation.
    Vogel M; Lai L; Rudolf MP; Curcio-Vonlanthen V; Miescher S; Stadler BM
    Hum Antibodies Hybridomas; 1996; 7(1):11-20. PubMed ID: 8886832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal booster vaccination against diphtheria and tetanus in man.
    Aggerbeck H; Gizurarson S; Wantzin J; Heron I
    Vaccine; 1997 Feb; 15(3):307-16. PubMed ID: 9139491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negatively charged liposomes as immunological adjuvant for tetanus and diphtheria toxoids.
    Popescu C; Durbaca S; Ivanov D
    Roum Arch Microbiol Immunol; 1998; 57(3-4):255-61. PubMed ID: 11845437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines.
    Mark A; Björkstén B; Granström M
    Vaccine; 1995 May; 13(7):669-73. PubMed ID: 7668036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit.
    Isaka M; Yasuda Y; Kozuka S; Miura Y; Taniguchi T; Matano K; Goto N; Tochikubo K
    Vaccine; 1998 Oct; 16(17):1620-6. PubMed ID: 9713937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine.
    Isaka M; Komiya T; Takahashi M; Yasuda Y; Taniguchi T; Zhao Y; Matano K; Matsui H; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2004 Aug; 22(23-24):3061-8. PubMed ID: 15297056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of IRIV- versus alum-adjuvanted diphtheria and tetanus toxoid vaccines in influenza primed mice.
    Zurbriggen R; Glück R
    Vaccine; 1999 Mar; 17(11-12):1301-5. PubMed ID: 10195764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulating role of toxoids-laden liposomes in oral immunization against diphtheria and tetanus infections.
    Mirchamsy H; Manhouri H; Hamedi M; Ahourai P; Fateh G; Hamzeloo Z
    Biologicals; 1996 Dec; 24(4):343-50. PubMed ID: 9088551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of chitosan microspheres for tetanus, diphtheria and divalent vaccines: a comparative study of subcutaneous and intranasal administration in mice.
    Hashem FM; Fahmy SA; El-Sayed AM; Al-Sawahli MM
    Pharm Dev Technol; 2013; 18(5):1175-85. PubMed ID: 21985525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral immunization against diphtheria and tetanus infections by fluid diphtheria and tetanus toxoids.
    Mirchamsy H; Hamedi M; Fateh G; Sassani A
    Vaccine; 1994 Oct; 12(13):1167-72. PubMed ID: 7530887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric diphtheria and tetanus toxoids-adsorbed vaccine: immune response to the first booster following the diphtheria and tetanus toxoids vaccine primary series.
    Pichichero ME; Barkin RM; Samuelson JS
    Pediatr Infect Dis; 1986; 5(4):428-30. PubMed ID: 3487779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid.
    Pirouzmand H; Khameneh B; Tafaghodi M
    Pharm Biol; 2017 Dec; 55(1):212-217. PubMed ID: 27927058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.